COVID-19 Immunity

No Gravatar

We spoke of opening schools yesterday.  The consideration has to include the fact that seemingly healthy folks are absolutely capable of infecting others.  As a matter of fact, we know that little kids harbor more viruses (10 to 100X more!) in their upper respiratory tract than the rest of us- which means they are MORE likely to infect  the rest of us.  And, asymptomatic folks (which seem to equal about 30% to 40% of the population harboring the  coronavirus) have the same viral load in their respiratory tract as those who manifest symptoms.

Continue reading COVID-19 Immunity

Share this:
Share this page via Email Share this page via Stumble Upon Share this page via Digg this Share this page via Facebook Share this page via Twitter
Share

The 3 R’s

No Gravatar

To open or not to open.  That really is the question.

Because if we don’t open our schools, we will never find a way to get most of our employees able to return to work.  They will have to stay home to monitor their kids and provide secondary instruction (or is that primary?) for when their kids don’t quite get the subject matter of the day.  Not to mention that many of our kids lack the resources for schooling at home.  (No computer, no internet.)  Maybe even more kids manifest food deficits (normally receiving free lunch and free breakfast at school)- and hungry kids just don’t learn well.

Continue reading The 3 R’s

Share this:
Share this page via Email Share this page via Stumble Upon Share this page via Digg this Share this page via Facebook Share this page via Twitter
Share

AI Drug Development?

No Gravatar

Enough about the pandemic.

We are plenty of regular problems- like antibiotic-resistant microbes.

Believe it or not, there are still some scientists left NOT working on vaccines or therapies for SARS-CoV-2 who are able to address this recalcitrant problem.

Continue reading AI Drug Development?

Share this:
Share this page via Email Share this page via Stumble Upon Share this page via Digg this Share this page via Facebook Share this page via Twitter
Share